: ABOUT ALEMBIC LIMITED

Alembic Limited, with an established presence in the Indian pharma industry has a proud,
historical track record going back one hundred years. With a turnover in excess of Rs. 1100
crores today, Alembic Limited is one of India’s leading integrated pharmaceutical companies.
We continue to enjoy leadership positions in antibiotics, anti-infective, anti-cough and also have
significant worldwide presence in specialty therapeutic areas such as cardiology, neurology,
diabetology, etc. We also have plans for expansion in Ophthalmology.

Alembic's manufacturing facilities are located Vadodara, Panelav in Gujarat, and at Baddi in
Himachal Pradesh. These facilities are approved by the US FDA, EDQM, TGA, MHRA, and
MCC.

Alembic Research Center (ARC) a world-class research organization provides a comprehensive

range of services in the areas of synthetic chemistry, formulations, NDDS and also preclinical
pharmacology, bioequivalence / bioanalytical studies. ARC, designed to state-of-the-art GLP
standards is spread over an area of 120,000 sq ft, manned by over 300 scientists working on
latest technology and systems.

Our current employee strength is in excess of 5100 across the country. A continuously expanding
organization, we invite dynamic, result-oriented professionals to join us across various functions.

.: MILESTONES

Alembic has been building high standards in the Indian pharmaceutical industry for almost a
hundred years. Please travel with us through the years...

 DMFs total filed to 32 . ANDAs total filed 19 and get approval for 4.
 Acquisition of Dabur Non On-Cology 24 Brands.
 Entered into licensing agreement for its Novel Drug Delivery Platform for Keppra® XR
(Levetiracetam Extended Release Tablets) with UCB
 Acquisition of Non-Oncology Business of M/s Dabur Pharma Ltd
 Acquisition of API Plant at Tal; Karakhadi, Dist Vadodara
 Launched ZERO Brand
 Commissioning of Baddi Plant.
 Launched BioArc Research Solutions
 Taken over the Bulk Drugs Unit of Darshak Limited.
 Started manufacturing facility at Village Bhimpore, Daman.
 Launched Generic Division.
 Inaugurated Cephalosporin – C manufacturing facility by Mr. Suresh Prabhu –
Honourable Union Minister of Chemicals & Fertilizers, GoI.
 Achieved ISO 14001 Certificate.
 Achieved ISO 9002 Certificate for its manufacturing facilities.
 Launched Clarithro – A brand of Clarithromycin.
 Launched Azithral Liquid
  Launched Roxid Liquid.
 Received Award for ‘Excellence in Environment Preservation and Pollution Control’ by
FGI.
 Received Award for ‘Excellence in Environment Preservation and Pollution Control’ by
FGI.
 Launched Azithral – A brand of Azithromycin.
 Received Second Chemexcil Award.
 Large Scale production of 6-APA (6 - Amino Penicillanic Acid) using immobilized
enzyme.
 Launched Roxid – A brand of Roxithromycin.
 Received First Chemexcil Award.
 Started manufacturing Ampicillin, Pharma Building was set up.
 R & D was approved by DSIR, GoI.
 Started Manufacturing Kanamycin by fermentation.
 Launched Althrocin – A brand of Erythromycin.
 A major break through as the Company started manufacturing Erythromycin.
 Received Dr. P.C. Ray Award for Quality.
 Started Manufacturing Streptomycin.
 Bulk Manufacturing of Vitamins B12 by fermentation.
 Inaugurated Penicillin plant by Late Mr. Lal Bahadur Shastri.
 Started R & D Activity.
 Started manufacturing Cough Syrup, Vitamins, tonics and Sulphur Drugs.
 Started manufacturing Chemicals and Vegetable Ghee
 Established a Sales Office in Calcutta.
 Branch Office in Madras was established.
 Company celebrated Silver Jubilee.
 French Distillery Plant worth Rs. 1 Lac along with machinery for Pharmaceutical
purposes was installed in Vadodara.
 A Joint Stock Company with a limited liability registered first in Bombay and then in
Vadodara. The Company was named Alembic Chemical Works Co. Ltd

Content provided by Alembic. Info Edge India Limited disclaims all warranties against
infringement

EMBIC GROUP OF COMPANIES

 Shreno Limited (Glass Division)

 Shreno Limited (Engineering Division)

 Paushak Limited
  BAGH
 DOMESTIC FORMULATIONS

Our extensive range of Finished Dosage Forms cover every aspect of human life. We possess
expertise in the manufacture of high volume Finished Dosage Forms and effectively control their
release profile. This expertise is in the field of sterile as well as non-sterile dosage forms.
Alembic has commissioned a solid Oral dosage facility approved by MCC South Africa and
MHRA UK

Find out more about :

 
Branded Formulations
Antibiotics & Anti bacterials Cough & Cold
Antihistamines NSAIDS
Oral Hypoglycemic Herbals & Nutraceuticals
Cardiovascular Others
 
For Business Inquiries please click here
 
Generics
At present we have 90 brands with extension in various forms covering the therapeutic segments
of Antibiotic, Cough & cold, NSAID, B-complex, C.V.Drugs etc.
 
Therapeutic segments Antiallergic
Anticold Preparation Anthelminitic
Antimalarials Antimicrobials
Antioxidants Antipyretics
Antiseptic Antispasmodic
Antiulcerants Cardiovascular Drugs
Corticosteroids Cough Preparations
Enzyme Preparation Mucolytics & Proteolytics
Nsaids Tranquiliser
Vitamin Preparations Others